A detailed history of Lsv Asset Management transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Lsv Asset Management holds 2,493,942 shares of JAZZ stock, worth $306 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
2,493,942
Previous 2,480,563 0.54%
Holding current value
$306 Million
Previous $265 Million 4.95%
% of portfolio
0.6%
Previous 0.58%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$100.57 - $116.37 $1.35 Million - $1.56 Million
13,379 Added 0.54%
2,493,942 $278 Million
Q2 2024

Aug 06, 2024

BUY
$103.94 - $118.98 $10.4 Million - $11.9 Million
99,705 Added 4.19%
2,480,563 $265 Million
Q1 2024

May 06, 2024

BUY
$115.19 - $132.77 $4.33 Million - $5 Million
37,631 Added 1.61%
2,380,858 $287 Million
Q4 2023

Feb 06, 2024

SELL
$114.26 - $136.0 $3.31 Million - $3.94 Million
-28,950 Reduced 1.22%
2,343,227 $288 Million
Q3 2023

Nov 03, 2023

BUY
$122.0 - $145.31 $6.79 Million - $8.08 Million
55,630 Added 2.4%
2,372,177 $307 Million
Q2 2023

Aug 02, 2023

SELL
$122.5 - $147.16 $227,360 - $273,128
-1,856 Reduced 0.08%
2,316,547 $287 Million
Q1 2023

May 02, 2023

BUY
$133.98 - $160.47 $35.2 Million - $42.1 Million
262,509 Added 12.77%
2,318,403 $339 Million
Q4 2022

Feb 08, 2023

BUY
$129.72 - $159.85 $38.3 Million - $47.1 Million
294,917 Added 16.75%
2,055,894 $328 Million
Q3 2022

Nov 07, 2022

BUY
$126.59 - $161.18 $3.71 Million - $4.72 Million
29,284 Added 1.69%
1,760,977 $235 Million
Q2 2022

Aug 10, 2022

SELL
$141.59 - $168.66 $10.8 Million - $12.9 Million
-76,299 Reduced 4.22%
1,731,693 $270 Million
Q1 2022

May 12, 2022

SELL
$129.64 - $160.7 $3.77 Million - $4.67 Million
-29,084 Reduced 1.58%
1,807,992 $281 Million
Q4 2021

Jan 28, 2022

SELL
$119.87 - $145.67 $4.94 Million - $6 Million
-41,190 Reduced 2.19%
1,837,076 $234 Million
Q3 2021

Nov 04, 2021

SELL
$128.64 - $184.79 $12.5 Million - $18 Million
-97,550 Reduced 4.94%
1,878,266 $245 Million
Q2 2021

Aug 04, 2021

SELL
$160.2 - $186.42 $15.5 Million - $18 Million
-96,555 Reduced 4.66%
1,975,816 $351 Million
Q1 2021

Apr 30, 2021

SELL
$150.19 - $173.5 $29.6 Million - $34.2 Million
-197,156 Reduced 8.69%
2,072,371 $341 Million
Q4 2020

Feb 08, 2021

SELL
$140.71 - $165.05 $24.1 Million - $28.3 Million
-171,430 Reduced 7.02%
2,269,527 $375 Million
Q3 2020

Oct 23, 2020

BUY
$105.46 - $144.13 $22.7 Million - $31.1 Million
215,526 Added 9.68%
2,440,957 $348 Million
Q2 2020

Aug 05, 2020

BUY
$95.68 - $121.88 $34.7 Million - $44.2 Million
363,015 Added 19.49%
2,225,431 $246 Million
Q1 2020

May 07, 2020

SELL
$87.74 - $152.74 $307,353 - $535,048
-3,503 Reduced 0.19%
1,862,416 $186 Million
Q4 2019

Feb 10, 2020

BUY
$117.65 - $153.73 $17 Million - $22.2 Million
144,628 Added 8.4%
1,865,919 $279 Million
Q3 2019

Nov 07, 2019

BUY
$125.18 - $143.24 $74.4 Million - $85.1 Million
594,171 Added 52.72%
1,721,291 $221 Million
Q2 2019

Aug 08, 2019

BUY
$125.55 - $144.48 $15.8 Million - $18.1 Million
125,470 Added 12.53%
1,127,120 $161 Million
Q1 2019

May 07, 2019

BUY
$121.81 - $142.95 $28.9 Million - $33.9 Million
237,190 Added 31.03%
1,001,650 $143 Million
Q4 2018

Feb 05, 2019

BUY
$115.94 - $166.74 $54 Million - $77.7 Million
466,168 Added 156.28%
764,460 $94.8 Million
Q3 2018

Nov 06, 2018

BUY
$161.01 - $180.57 $1.6 Million - $1.8 Million
9,956 Added 3.45%
298,292 $50.2 Million
Q2 2018

Aug 08, 2018

BUY
$146.33 - $183.18 $8.44 Million - $10.6 Million
57,666 Added 25.0%
288,336 $49.7 Million
Q1 2018

May 04, 2018

BUY
$135.59 - $157.16 $9.64 Million - $11.2 Million
71,100 Added 44.56%
230,670 $34.8 Million
Q4 2017

Feb 01, 2018

BUY
$131.06 - $150.39 $3.5 Million - $4.02 Million
26,740 Added 20.13%
159,570 $0
Q3 2017

Nov 13, 2017

BUY
$142.62 - $155.6 $18.9 Million - $20.7 Million
132,830
132,830 $19.4 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.7B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Lsv Asset Management Portfolio

Follow Lsv Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lsv Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Lsv Asset Management with notifications on news.